Evidence map›Paper›PMID 41530161›Full record

ArticleNature communications2026

Predicting age of respiratory syncytial virus infection from birth timing.

Chris G McKennan, Tebeb Gebretsadik, Steven M Brunwasser, Michael Nodzenski, Daniel J Jackson, James E Gern, Pingsheng Wu, Tina V Hartert

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chris G McKennanDepartment of Statistics, University of Pittsburgh; Pittsburgh, Pennsylvania, USA. chm195@pitt.edu.ORCID http://orcid.org/0000-0003-2096-8257
Tebeb GebretsadikDepartment of Biostatistics, Vanderbilt University Medical Center; Nashville, Tennessee, USA.
Steven M BrunwasserDepartment of Psychology, Rowan University; Glassboro, New Jersey, USA.
Michael NodzenskiRho Inc, Federal Systems Division, Durham, North Caroline, USA.
Daniel J JacksonDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
James E GernDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID http://orcid.org/0000-0002-6667-4708
Pingsheng WuDepartment of Biostatistics, Vanderbilt University Medical Center; Nashville, Tennessee, USA.ORCID http://orcid.org/0000-0003-4947-3063
Tina V HartertDepartment of Medicine, Vanderbilt University Medical Center; Nashville, Tennessee, USA. tina.hartert@vumc.org.ORCID http://orcid.org/0000-0001-7470-1166

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Dawn C Newcomb · 2011 to 2026
$34.9M
Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-UpUG3OD023282 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2016 to 2024
$19.3M
Children's Allergy and Asthma Data Repository (CADRE) SupplementU24AI179612 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern · 2024 to 2026
$3.2M
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthmaR01HL173480 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Tina V Hartert, PINGSHENG WU · 2024 to 2026
$2.3M
AHRQ HHS R01 HS018454NCATS NIH HHS UL1 TR000445NHLBI NIH HHS R01 HL173480NIAID NIH HHS U19 AI095227NIAID NIH HHS U24 AI179612NIH HHS UG3 OD023282U.S. Department of Health & Human Services | Agency for Healthcare Research and Quality (AHRQ) R01HS018454
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) infects nearly all children by age 2 to 3 years, and early-life infection-defined using active and passive surveillance with quantitative polymerase chain reaction- and serology-identified infection-has been implicated as a causal factor in childhood asthma. As such, identifying infants that are likely to be infected with RSV during this critical susceptibility window has important implications for identifying individuals at risk for chronic respiratory sequelae. However, determining the age of RSV infection in large populations is challenging because many infections are asymptomatic, making accurate detection dependent on intensive and costly surveillance. To address this, we developed a probability model for age of first RSV infection. It uses an infant's birthdate, demographic covariates, and publicly available RSV circulation data to determine the probability they were first infected at any age from birth to one year. Our model is interpretable, accounts for nearly 37% of the variance in age at first infection, and generalizes across four independent datasets collected from participants in the United States, where we use it to accurately predict age of first infection in two independent cohorts. Our work facilitates reliable estimation of the age of infant RSV infection during the first year of life without the need for active surveillance.

Indexed as

Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAge FactorsChild, PreschoolFemaleHumansInfantInfant, NewbornMaleRespiratory Syncytial VirusesUnited States

Identifiers

PMID41530161
PMCPMC12858871

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.